CVE-2020-27374

CVE-2020-27374 is a high-severity vulnerability in Drtrustusa Icheck Connect Bp Monitor Bp Testing 118 Firmware with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-294.

Key facts

Description

Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1 is vulnerable to a Replay Attack to BP Monitoring.

Frequently asked questions

What is CVE-2020-27374?
Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1 is vulnerable to a Replay Attack to BP Monitoring.
How severe is CVE-2020-27374?
CVE-2020-27374 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over an adjacent network with high attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2020-27374 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (55th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-27374?
CVE-2020-27374 affects Drtrustusa Icheck Connect Bp Monitor Bp Testing 118 Firmware. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2020-27374?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2020-27374 published?
CVE-2020-27374 was published on 2022-04-07 and last updated on 2026-07-05.

References

Affected products (1)

More vulnerabilities in Drtrustusa Icheck Connect Bp Monitor Bp Testing 118 Firmware

All CVEs affecting Drtrustusa Icheck Connect Bp Monitor Bp Testing 118 Firmware →

Other CWE-294 (Authentication Bypass by Capture-replay) vulnerabilities

Browse all CWE-294 (Authentication Bypass by Capture-replay) vulnerabilities →